PMHS.US PMHS

Healthcare Pharmaceutical Retailers USA Stocks
0.1250 USD
Close of Nov 18, 2026
0.0650 0.7999
Market cap
USD 3.55M
P/E
-
P/B
0.67x
ROE
-63.2%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is PMHS.US undervalued?

Graham number

The Graham number of PMHS cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

PMHS fundamental analysis

No fundamental analysis for PMHS yet.

PMHS stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About PMHS

Polomar Health Services, Inc. operates as a retail compounding pharmacy in the United States. The company owns SlimRx, a weight loss focused online platform connects patients with licensed physicians to prescribe weight loss medications, such as semaglutide compounded with vitamin B-12 and/or metformin; Tofacitinib, it treats rheumatoid arthritis by inhibiting JAK to reduce inflammation and pain; Semaglutide GLP-1, which regulates blood sugar, appetite, and weight in diabete…

Full company profile